Proportion of bloodstream infection due to Escherichia coli resistant in Netherlands

Netherlands: Proportion of bloodstream infection due to Escherichia coli resistant was 8.1% in 2023. ▲ Rising

Latest (2023)
8.1%
Change on year
up 7.0%
World rank
56th
of 58 countries
All-time high
8.1%
in 2023
All-time low
6.2%
in 2017
Years of data
7
2017–2023

Proportion of bloodstream infection due to Escherichia coli resistant in Netherlands, 2017–2023

024682017202020232017: 6.22018: 7.32019: 7.22020: 6.52021: 6.72022: 7.62023: 8.1

Source: World Health Organization, Global Health Observatory.

Analysis

Netherlands recorded 8.1% for proportion of bloodstream infection due to escherichia coli resistant in 2023. That is the highest value across all 7 years on record.

The figure is up 7.0% on the previous year and up 32.1% over ten years.

Netherlands ranks 56th of 58 countries on this measure, in the bottom quarter.

Proportion of bloodstream infection due to Escherichia coli resistant in Netherlands, year by year

Annual values for Proportion of bloodstream infection due to Escherichia coli resistant to third-generation cephalosporins (%) in Netherlands, 2017 to 2023.
Year Value Change
2017 6.2%
2018 7.3% +18.3%
2019 7.2% -1.0%
2020 6.5% -9.3%
2021 6.7% +2.1%
2022 7.6% +13.8%
2023 8.1% +7.0%

Averages by decade

DecadeAverage LowestHighest Years
2010s 6.9% 6.2% 7.3% 3
2020s 7.2% 6.5% 8.1% 4

Countries ranked near Netherlands

  1. 53 Germany 9.8% compare
  2. 54 France 9.1% compare
  3. 55 Finland 8.7% compare
  4. 57 Sweden 7.9% compare
  5. 58 Norway 5.7% compare

See the full ranking of 58 places →

More health data for Netherlands

All data for Netherlands →

Frequently asked questions

What is proportion of bloodstream infection due to escherichia coli resistant in Netherlands?
Proportion of bloodstream infection due to escherichia coli resistant in Netherlands was 8.1% in 2023, according to World Health Organization, Global Health Observatory.
What is the highest proportion of bloodstream infection due to escherichia coli resistant recorded in Netherlands?
The highest recorded value was 8.1% in 2023.
What is the lowest proportion of bloodstream infection due to escherichia coli resistant recorded in Netherlands?
The lowest recorded value was 6.2% in 2017.
How does Netherlands rank for proportion of bloodstream infection due to escherichia coli resistant?
Netherlands ranks 56th out of 58 countries with data for 2023.
Is proportion of bloodstream infection due to escherichia coli resistant rising or falling in Netherlands?
Over the last ten years it is up 32.1%. The long-run trend across the full record is rising.
Where does this Netherlands data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of Proportion of bloodstream infection due to Escherichia coli resistant to third-generation cephalosporins (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 7 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

Proportion of bloodstream infection due to Escherichia coli resistant in Netherlands. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 10 September 2026, from https://health.statizoid.com/stat/proportion-of-bloodstream-infection-due-to-escherichia-coli-resistant-to-third-generation/netherlands/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/proportion-of-bloodstream-infection-due-to-escherichia-coli-resistant-to-third-generation/netherlands/">Proportion of bloodstream infection due to Escherichia coli resistant in Netherlands</a> — Statizoid

About this data

Indicator
Proportion of bloodstream infection due to Escherichia coli resistant to third-generation cephalosporins (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
58 places, 386 data points, 2016–2023
Last refreshed